Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies

Cancer immunotherapy has emerged as a mainstream therapy option in the battle against cancer. Pre-clinical data demonstrates the ability of immunotherapy to harness the immune system to fight disseminated malignancy. Clinical translation has failed to recapitulate the promising results of pre-clin...

Descripció completa

Dades bibliogràfiques

Autors principals:	Arta Monir Monjazeb, Anthony E Zamora, Steven K Grossenbacher, Annie eMirsoian, Gail D Sckisel, William J Murphy
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2013-07-01
Col·lecció:	Frontiers in Oncology
Matèries:	Immune Tolerance Radiotherapy cancer immunotherapy immune suppression immune surveillance bystander T-cells
Accés en línia:	http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00197/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!